MicroStrategy Forecast, price target & analysts
Why the stock moved Beta
MicroStrategy Target price 2025 - Analyst rating & recommendation
MicroStrategy Classifications & Recommendation:
MicroStrategy Price Target
| Target Price | $561.00 |
| Price | $186.50 |
| Potential | 200.80% |
| Number of Estimates | 18 |
| 18 Analysts have issued a price target MicroStrategy 2026 . The average MicroStrategy target price is $561.00. This is 200.80% higher than the current stock price. The highest price target is $740.25 296.92% , the lowest is $176.75 5.23% . | |
| A rating was issued by 22 analysts: 19 Analysts recommend MicroStrategy to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the MicroStrategy stock has an average upside potential 2026 of 200.80% . Most analysts recommend the MicroStrategy stock at Purchase. |
Sales and Margin forecast 2025, 2026 & 2027
16 Analysts have issued a sales forecast MicroStrategy 2025 . The average MicroStrategy sales estimate is $472m . This is 0.62% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $499m 5.08% , the lowest is $431m 9.21% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $463m | 6.61% |
|---|---|---|
| 2025 | $472m | 1.84% |
| 2026 | $492m | 4.24% |
| 2027 | $477m | 3.13% |
7 Analysts have issued an MicroStrategy EBITDA forecast 2025. The average MicroStrategy EBITDA estimate is $4.2b . This is 65.19% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $8.6b 28.63% , the lowest is $32.8m 99.73% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-45.3m | 395.56% |
|---|---|---|
| 2025 | $4.2b | 9,327.54% |
| 2026 | $11.4b | 171.92% |
| 2027 | $3.5b | 69.59% |
EBITDA Margin
| 2024 | -9.78% | 416.48% |
|---|---|---|
| 2025 | 885.82% | 9,160.74% |
| 2026 | 2,310.82% | 160.87% |
| 2027 | 725.39% | 68.61% |
15 MicroStrategy Analysts have issued a net profit forecast 2025. The average MicroStrategy net profit estimate is $12.2b . This is 57.79% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $23.9b 210.06% , the lowest is $4.5b 41.63% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-1.2b | 371.87% |
|---|---|---|
| 2025 | $12.2b | 1,143.87% |
| 2026 | $8.6b | 29.74% |
| 2027 | $13.1b | 53.60% |
Net Margin
| 2024 | -251.73% | 391.11% |
|---|---|---|
| 2025 | 2,580.24% | 1,125.01% |
| 2026 | 1,739.30% | 32.59% |
| 2027 | 2,757.94% | 58.57% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
15 Analysts have issued a MicroStrategy forecast for earnings per share. The average MicroStrategy EPS is $42.42 . This is 73.36% higher than earnings per share in the financial year 2024. The highest EPS forecast is $83.35 240.62% , the lowest is $15.69 35.88% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-6.06 | 333.98% |
|---|---|---|
| 2025 | $42.42 | 800.00% |
| 2026 | $29.80 | 29.75% |
| 2027 | $45.78 | 53.62% |
P/E ratio
| Current | 7.62 | 104.61% |
|---|---|---|
| 2025 | 4.40 | 42.27% |
| 2026 | 6.26 | 42.27% |
| 2027 | 4.07 | 34.98% |
Based on analysts' sales estimates for 2025, the MicroStrategy stock is valued at an EV/Sales of 130.75 and an P/S ratio of 113.54 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 129.93 | 17.06% |
|---|---|---|
| 2025 | 130.75 | 0.63% |
| 2026 | 125.43 | 4.07% |
| 2027 | 129.49 | 3.24% |
P/S ratio
| Current | 112.84 | 23.62% |
|---|---|---|
| 2025 | 113.54 | 0.63% |
| 2026 | 108.93 | 4.07% |
| 2027 | 112.45 | 3.24% |
Current MicroStrategy Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Monness, Crespi, Hardt |
Sell
➜
Neutral
|
Upgrade | Nov 10 2025 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Nov 03 2025 |
| HC Wainwright & Co. |
Buy
➜
Buy
|
Unchanged | Nov 03 2025 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 31 2025 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Oct 31 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 31 2025 |
| Citigroup |
➜
Buy
|
Initiated | Oct 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
Monness, Crespi, Hardt:
Sell
➜
Neutral
|
Nov 10 2025 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Nov 03 2025 |
|
Unchanged
HC Wainwright & Co.:
Buy
➜
Buy
|
Nov 03 2025 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 31 2025 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Oct 31 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 31 2025 |
|
Initiated
Citigroup:
➜
Buy
|
Oct 21 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
